How many insider trades does FilingIQ track for RNXT?

FilingIQ tracks 49 Form 4 insider transactions for RNXT (RenovoRx, Inc.), covering filings from May 23, 2022 onwards. 1 of those are dated within the last 90 days.

Are RNXT insiders net buyers or net sellers?

Across the full Form 4 history for RNXT, 36 transactions (73%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RNXT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is RNXT in?

RenovoRx, Inc. (RNXT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $51.07M.

RNXT insider trading

NasdaqCM Healthcare

RenovoRx, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

73% / 0%

Market cap

$51.07M

About RenovoRx, Inc.

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.

Company website: renovorx.com

RNXT insider activity at a glance

FilingIQ tracks 49 insider transactions for RNXT in filings since May 23, 2022. The most recent transaction is dated Sep 10, 2026.

Across the full history, 36 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RNXT insider trades is 61.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live RNXT trades on FilingIQ Raw filings on SEC EDGAR

Latest RNXT Form 4 filings

VOLL MARK Chief Financial Officer

A Sep 15, 2026

RYAN UNA S

J Jun 24, 2026

VOLL MARK Chief Financial Officer

P May 21, 2026

Bagai Shaun Chief Executive Officer

A Apr 7, 2026

VOLL MARK Chief Financial Officer

A Apr 7, 2026

Gentry Leesa Chief Clinical Officer

A Apr 7, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Top insiders trading RNXT

VOLL MARK

5 trades · score 74.5

Frequently asked

How many insider trades does FilingIQ track for RNXT?: FilingIQ tracks 49 Form 4 insider transactions for RNXT (RenovoRx, Inc.), covering filings from May 23, 2022 onwards. 1 of those are dated within the last 90 days.
Are RNXT insiders net buyers or net sellers?: Across the full Form 4 history for RNXT, 36 transactions (73%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RNXT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is RNXT in?: RenovoRx, Inc. (RNXT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $51.07M.

Methodology & sources

Every RNXT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.